BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Protective effects of selenium nanoparticle-enriched Lactococcus lactis NZ9000 against enterotoxigenic Escherichia coli K88-induced intestinal barrier damage in mice. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: Issue Pages: AEM0163621 Pub: 2021 Sep 15 Epub: 2021 Sep 15 Authors Chen Y , Qiao L , Song X , Ma L , Dou X , Xu C , |
|
|
Investigating lactic acid bacteria genus Lactococcus lactis properties: Antioxidant activity, antibiotic resistance, and antibacterial activity against multidrug-resistant bacteria Staphylococcus aureus. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 10 Issue 11 Pages: e31957 Pub: 2024 Jun 15 Epub: 2024 May 28 Authors Hamdaoui N , Benkirane C , Bouaamali H , Azghar A , Mouncif M , Maleb A , Hammouti B , Al-Anazi KM , Kumar P , Yadav KK , Choi JR , Meziane M , |
|
|
Lactococcus lactis KA-FF 1-4 reduces vancomycin-resistant enterococci and impacts the human gut microbiome. ✅
Go to Publication ✅
3 Biotech (3 Biotech ) Vol: 10 Issue 7 Pages: 295 Pub: 2020 Jul Epub: 2020 Jun 8 Authors Plupjeen SN , Chawjiraphan W , Charoensiddhi S , Nitisinprasert S , Nakphaichit M , |
|
|
Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 15072 Pub: 2018 Oct 10 Epub: 2018 Oct 10 Authors Carvalho R , Vaz A , Pereira FL , Dorella F , Aguiar E , Chatel JM , Bermudez L , Langella P , Fernandes G , Figueiredo H , Goes-Neto A , Azevedo V , |
|
|
Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 15072 Pub: 2018 Oct 10 Epub: 2018 Oct 10 Authors Carvalho R , Vaz A , Pereira FL , Dorella F , Aguiar E , Chatel JM , Bermudez L , Langella P , Fernandes G , Figueiredo H , Goes-Neto A , Azevedo V , |
|
|
Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 15072 Pub: 2018 Oct 10 Epub: 2018 Oct 10 Authors Carvalho R , Vaz A , Pereira FL , Dorella F , Aguiar E , Chatel JM , Bermudez L , Langella P , Fernandes G , Figueiredo H , Goes-Neto A , Azevedo V , |
|
|
Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 15072 Pub: 2018 Oct 10 Epub: 2018 Oct 10 Authors Carvalho R , Vaz A , Pereira FL , Dorella F , Aguiar E , Chatel JM , Bermudez L , Langella P , Fernandes G , Figueiredo H , Goes-Neto A , Azevedo V , |
|
|
Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 15072 Pub: 2018 Oct 10 Epub: 2018 Oct 10 Authors Carvalho R , Vaz A , Pereira FL , Dorella F , Aguiar E , Chatel JM , Bermudez L , Langella P , Fernandes G , Figueiredo H , Goes-Neto A , Azevedo V , |
|
|
Suppressive Effect of Lactococcus lactis subsp. cremoris YRC3780 on a Murine Model of Japanese Cedar Pollinosis. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 11 Issue 11 Pages: Pub: 2022 Nov 14 Epub: 2022 Nov 14 Authors Uchida K , Iida K , Fujioka I , Hachimura S , Kaminuma O , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
